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Abstract 
BACKGROUND: Wilshire and colleagues suggest that we have overestimated the number of 
patients that recover from chronic fatigue syndrome (CFS) after receiving a course of either 
cognitive behaviour therapy (CBT) or graded exercise therapy (GET), as reported in a 
secondary analysis of outcome data from the PACE trial. We provide counter-arguments to 
this view.  
PURPOSE: To provide an alternative view to that offered by Wilshire and colleagues. 
METHODS: We review the two different analyses of PACE trial outcome data to estimate 
recovery, and compare these to other published trials and cohort studies. 
RESULTS: While there is no gold standard for recovery from chronic fatigue syndrome, 
previous trials and cohort studies provide support for our analysis of recovery rates in the 
PACE trial. Our finding that 22% of participants recover from the current episode of CFS 
after either CBT or GET, compared to 8% after adaptive pacing therapy and 7% after 
specialist medical care alone, is consistent with the literature.  
CONCLUSIONS: Our original conclusions that “...recovery from CFS is possible, and that 
CBT and GET are the therapies most likely to lead to recovery” is an important, reasonable, 
and hopeful message for both clinicians and patients.  
Keywords: Chronic fatigue syndrome, myalgic encephalomyelitis, cognitive behaviour 
therapy, graded exercise therapy, recovery 
Text – 1531 words  
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The PACE trial found that, when added to specialist medical care, both cognitive behaviour 
therapy (CBT) and graded exercise therapy (GET) are safe treatments for chronic fatigue 
syndrome (CFS, and are more effective than both adaptive pacing therapy (APT) added to 
SMC and SMC alone [1]. These findings emerge both from our planned detailed statistical 
analysis [1, 2], and from the analysis originally outlined in the published protocol [3-5]. 
Furthermore, an updated systematic review of all eight trials of exercise therapy for CFS, 
which included the PACE trial data, confirmed that exercise therapy is an effective and safe 
treatment for CFS, and that it is as effective as CBT [6].   
So, why do Wilshire and colleagues cast doubt on these findings, and even suggest that 
clinicians and patients have been misled [7]? It is important to note that their argument 
focusses not on the primary trial outcomes, outlined above, but on one of a number of 
secondary analysis of the PACE trial data, which explored whether patients were more likely 
to recover from their current episode of CFS after a course of either CBT or GET, compared 
to APT and SMC [8]. Our analysis suggested that they were more likely to recover, whilst 
Wilshire and colleagues suggest they were not. The question we address here is which view is 
right, given that there is no generally agreed measure of recovery.  
 On first glance it may appear that we were wrong. In particular that got our chosen 
thresholds wrong, as in our analysis 13% of participants met the recovery criterion of being 
within the normal range (population mean, minus one standard deviation) for physical 
functioning when they entered the trial. This observation would support the argument that 
this threshold we chose was too lenient to be used to assess recovery. However, further 
scrutiny shows that this argument is misleading as being within normal range on this single 
measure was only one of the criteria we used to define recovery; to be regarded as recovered 
participants also had to meet four additional criteria [8]. These were: (1) being within the 
population normal range for fatigue; (2) being within the normal range for both fatigue and 
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physical functioning (only 3 out of 640 (<1%) patients satisfied this criterion at baseline); (3) 
no longer meeting the Oxford definition for CFS, which included no longer meeting trial 
severity eligibility for entry into the trial for either fatigue (binary score of 5 or fewer out of 
11) or physical function (score of 70 or more out of 100) (no patient met this criterion at 
baseline); and (4) self-rating their overall health (not just CFS) as “very much better” or 
“much better” compared to trial entry (by definition no one met this criterion at baseline). 
Therefore, even if it is argued that the threshold we used for physical function was set too 
low, no participant met our full criteria for recovery at baseline. 
Our findings differ from those of Wilshire’s co-authors’ who report that only 7%, 4%, and 
3% of participants recovered for CBT, GET, and SMC respectively [7, 9]. They don’t 
mention the figure for APT, which was 2% [9]. Why is there such discrepancy between these 
two analyses? The main reason is that the analysis adopted by Wilshire and colleagues used 
thresholds that we proposed in the outline analysis plan taken from our published protocol 
[3]. These were: fatigue binary score of < 4/11, SF36 physical function score of >80/100, not 
meeting the Oxford definition of having CFS, and participant rating of overall health as “very 
much better” [8]. We changed these thresholds for our detailed analysis plan because, after 
careful consideration and consultation, we concluded that they were simply too stringent to 
capture clinically meaningful recovery [8]. For instance, we decided that rating one’s overall 
health as “much better” or “very much better” was more consistent with recovery on this 
criterion than only “very much better”. Another more minor reason may be that Wilshire’s 
and colleagues imputed missing data by last observation carried forward, a method likely to 
reduce the observed rate of recovery [7, 9].  
These differences in definition of recovery make it unsurprising that the two papers report 
different results. And as we wrote in our paper, “the main limitation of this analysis is the 
absence of a generally agreed measure of recovery” [8]. This caveat of course also applies to 
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the analysis done by Matthees and colleagues. Given that there is no ‘right answer’ to what is 
recovery, we might reasonably ask which of the two definitions of recovery is most clinically 
valid. 
What have others studies found regarding recovery? 
One way to address the question of the clinical validity of each definition of recovery is to 
review the recovery rates reported from naturalistic cohort studies. Cairns and Hotopf [10] 
systematically reviewed follow-up studies (the majority not involving any treatment) of 
patients with operationally defined CFS, and found a median (range) of only 7% (0–48%) 
recovered over time. This percentage is the same as the one we observed following SMC in 
the PACE trial, and provides some support for the validity of this finding.   
We can also compare results from a previous trial of CBT. In a five year follow-up study of a 
trial comparing CBT to relaxation therapy, Deale and colleagues [11] found that 24% of 25 
patients met operationalised criteria for recovery at 5 years, compared to 4% of 28 patients 
with relaxation therapy. This study used criteria for recovery closer to Matthees’ and 
colleagues analysis (although in Deale’s study recovery was measured five years after the 
trial had ended, with a greater chance of recovery with time [10]). Despite the more stringent 
criteria used, this long term follow up study supports the validity of our finding that 22% of 
participants were recovered after receiving CBT. 
Other studies found similar results. When applying operationalised criteria (no longer 
fatigued, able to resume activities, and a perception of health and fatigue similar to that of a 
healthy person) to a cohort of 96 patients who had received CBT, 23% were rated as 
‘recovered’ after treatment [12]. Interestingly, this Dutch Group found that having a 
comorbid illness reduced the numbers recovering, which supports our arguably conservative 
use of a rating of overall health to assess recovery [12]. Using similar criteria and thresholds 
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to those used in the PACE trial, Flo and Chalder found that 18% of 140 patients were 
recovered six months after receiving a course of CBT in a routine clinical setting [13]. These 
two cohort studies therefore provide further support for our finding that 22% of participants 
recovered after CBT, rather than the 7% reported by Wilshire et al. [7, 9]. Furthermore, the 
outcomes from CBT do vary between centres internationally, and it may be that UK 
outcomes could be improved [14]. 
Answers to other criticisms by Wilshire and colleagues 
Wilshire  used a study of age appropriate normal data from the six minute walking test (how 
far a patient can walk in six minutes)  to suggest that participants in the PACE trial had not  
recovered as measured by this test [7]. However, as we have already indicated in journal 
correspondence, it is not valid to compare the walking test used in PACE to population 
norms, as it was administered in a non-standard way in the PACE trial [15]. Because of our 
concerns about the welfare of patients with CFS coping with physical exertion, no 
encouragement was given to participants during this test. This is in contrast to other studies in 
which  encouragement was used [16], and found to make a difference [17]. In the PACE trial 
participants were told:  “You should walk continuously if possible, but can slow down or stop 
if you need to.” The PACE walking test data  are therefore not comparable with data 
collected in other studies. 
Finally, Wilshire et al believe that the PACE participants’ self-reported outcomes may have 
been influenced by the expectations they had of the therapy they were allocated to [7]. This is 
most unlikely however as we measured these expectations before participants started 
treatment, and found that 72% were confident about APT, compared to 57% about CBT [1]; 
yet three times as many participants were found to be recovered after CBT than after APT 
[8]. 
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Summary and conclusions 
To summarise, we accept and have made clear in our paper that measuring recovery from 
CFS with limited data is not an exact science. Consequently the clinical validity of our 
findings that 22% of patients recovering with either CBT or GET is reasonably disputable [8, 
15]. However, a review of the published literature indicates that other studies, including those 
that used more stringent criteria, report recovery rates closer to the ones we reported than to 
those reported by Wilshire and colleagues.  The important implications for both clinicians 
and patients are: First, this reanalysis of PACE data does not cast any doubt on the findings 
that that both CBT and GET are more effective treatments than either APT or SMC alone [1]. 
Second, whilst definitions of recovery can be disputed the literature supports our conclusions 
that “...recovery from CFS is possible, and that CBT and GET are the therapies most likely to 
lead to recovery.” [8].      
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